Prothrombotic disorders and ischemic stroke in children

Seminars in Pediatric Neurology

Volumn 7, Issue 4, 2000, Pages 301-308

  Chan, A K C ^a,b   DeVeber, Gabrielle ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5A; LIPOPROTEIN; PHOSPHOLIPID ANTIBODY; PLASMINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ANTITHROMBIN DEFICIENCY; CEREBROVASCULAR ACCIDENT; DYSFIBRINOGENEMIA; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; IRON DEFICIENCY ANEMIA; MORBIDITY; MORTALITY; POLYCYTHEMIA; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RECURRENT DISEASE; REVIEW; SECONDARY PREVENTION; STROKE; THROMBOCYTOPATHY; THROMBOSIS;

EID: 0034517210     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1053/spen.2000.20075     Document Type: Article

References (72)

1. Formation of the fibrin clot: The balance of procoagulant and inhibitory factors
2. Overview of hemostasis
3. The natural history of homocystinuria due to cystathionine beta-synthase deficiency
4. Infantile type of homocystinuria with 5,10-methylenetetrahydrofolate reductase deficiency
5. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
6. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
7. Increased plasma homocysteine concentration in patients with chronic renal failure
8. Hyperhomocysteinemia, atherosclerosis and thrombosis
9. Clinical manifestations and management of inherited thrombophilia: Retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S
10. New molecular insights into the genetics of thrombophilia: Resistance to activated protein C caused by Arg 506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis
11. Mutation in blood coagulation factor V associated with resistance to activated protein C
12. Reduced response to activated protein C is associated with increased risk for cerebrovascular disease
13. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
14. A prothrombin gene mutation is significantly associated with venous thrombosis
15. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis
16. Neonatal purpura fulminans and transient protein C deficiency
17. Hereditary and acquired antithrombin deficiency
18. Antiphospholipid antibodies in paediatrics
19. Recent insights into antiphospholipid antibody-mediated thrombosis
20. Immunology and clinical importance of antiphospholipid antibodies
21. Antiphosphatidyl serine antibodies are independently associated with ischemic stroke
22. Clinical significance of lupus anticoagulants in children
23. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: A cross-sectional study
24. Management of patients with hereditary hypercoagulable disorders
25. Type I congenital plasminogen deficiency is not a risk factor for thrombosis
26. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members
27. Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: A statistical analysis in 20 kindreds
28. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency
29. The A-844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers
30. Venous thrombosis and tissue plasminogen activator release deficiency: A family study
31. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age
32. Sticky platelet syndrome
33. The alpha2 gene coding sequence T807/A 873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients
34. Platelet adhesion to collagen: An update
35. Hematological disorders and ischemic stroke
36. Inherited or acquired disorders of blood coagulation in children with neurovascular complications
37. An unusual cause of cerebral venous thrombosis in a four-year-old child
38. Cerebral thromboembolism due to antithrombin III deficiency in two children
39. Activated protein C resistance in childhood stroke
40. Cerebral infarction and antiphospholipid syndrome in children
41. Evaluation of hyperhomocysteinaemia in children with stroke
42. Inherited prothrombotic states and ischaemic stroke in childhood
43. Risk factors for arterial ischemic stroke in children
44. Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood
45. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood
46. Prothrombotic disorders in infants and children with cerebral thromboembolism
47. Prevalence of the factor V leiden mutation in children and neonates with thromboemholic disease
48. Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis
49. Prothrombotic risk factors in childhood stroke and venous thrombosis
50. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children
51. Factor V Leiden, prothrombin 20210G → A and the MTHFR C677T mutations in childhood stroke
52. Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke
53. Hyperhomocysteinemia: A risk factor for ischemic stroke in children
54. Children with stroke: Polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status
55. Childhood stroke associated with protein C or S deficiency and primary antiphospholipid syndrome
56. Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke
57. Iron deficiency: A cause of stroke in infants and children
58. Genetic causes of childhood stroke
59. Stoke in the young: A four-year study, 1968 to 1972
60. Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke
61. Pediatric victims of unexplained stroke and their families: Familial lipid and lipoprotein abnormalities
62. Migraine in children: Association with primary and familial dyslipoproteinemias
63. Inherited thrombophilia: Part 1
64. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis
65. Factor V Leiden mutation in cerebral venous thrombosis
66. Cerebral venous sinus thrombosis in infancy and childhood: Role of genetic and acquired risk factors of thrombophilia
67. Superior sagittal sinus thrombosis in a child with protein S deficiency
68. Cerebral vein thrombosis in childhood systemic lupus erythematosus
69. Cerebral venous thrombosis in a child with iron deficiency anemia and thrombocytosis
70. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis
71. Cerebral venous thrombosis due to high-altitude polycythemia: Case report